SCHEMBL13133763

SCHEMBL13133763

Cc1ccc(-c2ccc(N(c3ccc(-c4cn5ccccc5n4)cc3)c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A3 P47895 2/20 0.48
▸ SLC2A1 P11166 1/20 0.48
▸ NPC1 O15118 11/20 0.46
▸ RAB9A P51151 11/20 0.46
▸ SMN1; SMN2 Q16637 7/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ PKM P14618 4/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ KDM4E B2RXH2 9/20 0.46
▸ EPHX2 P34913 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ GFER P55789 2/20 0.45
▸ HPGD P15428 3/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ APP P05067 1/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13133765 0.93 SLC2A1 (0.45) ALDH1A3SLC2A1NPC1RAB9ASMN1; SMN2
SCHEMBL13133759 0.92 RAB9A (0.49) ALDH1A3SLC2A1NPC1RAB9ASMN1; SMN2
SCHEMBL2813623 0.91 RAB9A (0.50) ALDH1A3NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL13133747 0.91 RAB9A (0.43) ALDH1A3SLC2A1NPC1RAB9ASMN1; SMN2
SCHEMBL13133772 0.90 SLC2A1 (0.47) ALDH1A3SLC2A1NPC1RAB9ASMN1; SMN2
SCHEMBL13043653 0.88 RAB9A (0.58) ALDH1A3NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL13133733 0.88 RAB9A (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1PKM
SCHEMBL13133738 0.87 RAB9A (0.44) ALDH1A3NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL13133736 0.87 RAB9A (0.44) ALDH1A3NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL13133732 0.86 RAB9A (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853403-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-07 — — US disclosed
US-8853403-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-10-07 — — US disclosed
US-20130130061-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-05-23 — — US disclosed
US-20130130061-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-05-23 — — US disclosed
US-8329917-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-12-11 — — US disclosed
US-8329917-B2 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-12-11 — — US disclosed
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-09-30 — — US disclosed
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100244670-A1 Heterocyclic Compound and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using the Same CRY1, LAGE3, NR2E3 ALDH1A3 409/4885SLC2A1 4846/4885NPC1 4412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback